R-2-HG Wild-type IDH1 and IDH2 catalyze the reaction by converting isocitrate and NADP + into -KG and CO 2 with the concomitant generation of NADPH in the cytosol and mitochondrial matrix
Potential Benefits: A Summary Based on the available (predominantly preclinical) literature, the following potential benefits have been identified: Risks & Safety Considerations Known & Reported Side Effects Because large-scale human trials are lacking, our understanding of the side effect profile is limited
What Is PDA (BPC-157-Arginine)
Besides inhibiting the mitochondrial autophagy process, morphological altered mitochondrial hyperactivated P53 and enhanced SOD enzyme activity (28, 57)
(Frontiers in Pharmacology, 2022) reports a half-life under 30 minutes after IM or IV administration in rodent and dog models, which is why split-dose schedules appear in the literature
Units assume a U100 insulin syringe (100 units = 1 mL on U-100)